Skip to main content

Purdue Pharma's payments to Sacklers soared amid opioid crisis

By The New York Times  
   December 16, 2019

As scrutiny of Purdue Pharma’s role in the opioid epidemic intensified during the past dozen years, its owners, members of the Sackler family, withdrew more than $10 billion from the company, distributing it among trusts and overseas holding companies, according to a new audit commissioned by Purdue.

Full story

Get the latest on healthcare leadership in your inbox.